These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 11548736)
1. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Leucht S Neurology; 2001 Aug; 57(4):747. PubMed ID: 11548736 [No Abstract] [Full Text] [Related]
2. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Sa DS; Lang AE Neurology; 2001 Aug; 57(4):747. PubMed ID: 11524507 [No Abstract] [Full Text] [Related]
3. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Goetz CG; Blasucci LM; Leurgans S; Pappert EJ Neurology; 2000 Sep; 55(6):789-94. PubMed ID: 10993997 [TBL] [Abstract][Full Text] [Related]
4. Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine. Rudolf J; Ghaemi M; Schmülling S Eur Psychiatry; 1999 Oct; 14(6):356-7. PubMed ID: 10572371 [TBL] [Abstract][Full Text] [Related]
5. Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine. Onofrj M; Thomas A; Bonanni L; Iacono D; Gambi F Neurol Sci; 2000 Aug; 21(4):209-15. PubMed ID: 11214659 [TBL] [Abstract][Full Text] [Related]
6. Olanzapine for psychosis in Parkinson's disease. Sa DS; Lang AE Neurology; 2001 Jun; 56(12):1781. PubMed ID: 11425961 [No Abstract] [Full Text] [Related]
7. Olanzapine treatment for dopaminergic-induced hallucinations. Ondo WG; Levy JK; Vuong KD; Hunter C; Jankovic J Mov Disord; 2002 Sep; 17(5):1031-5. PubMed ID: 12360554 [TBL] [Abstract][Full Text] [Related]
9. Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study. Friedman JH; Goldstein S; Jacques C Clin Neuropharmacol; 1998; 21(5):285-8. PubMed ID: 9789708 [TBL] [Abstract][Full Text] [Related]
10. Worsening of motor features of parkinsonism with olanzapine. Molho ES; Factor SA Mov Disord; 1999 Nov; 14(6):1014-6. PubMed ID: 10584679 [TBL] [Abstract][Full Text] [Related]
11. The effects of risperidone and olanzapine on the indications for clozapine. Ganguli R; Brar JS Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203 [TBL] [Abstract][Full Text] [Related]
13. Uncommon side effects associated with olanzapine. A case report. Farooque R Pharmacopsychiatry; 2003; 36(2):83. PubMed ID: 12734767 [No Abstract] [Full Text] [Related]
14. Riluzole and olanzapine in Huntington's disease. Bonelli RM; Niederwieser G; Diez J; Költringer P Eur J Neurol; 2002 Mar; 9(2):183-4. PubMed ID: 11882065 [No Abstract] [Full Text] [Related]
15. [The use of clozapine and levodopa for the treatment of persistent visual hallucinations and parkinsonism in Lewy body dementia]. Archie A; Persoons P; Vandenbulcke M Tijdschr Psychiatr; 2013; 55(4):287-91. PubMed ID: 23595844 [TBL] [Abstract][Full Text] [Related]
17. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia. Marsh L; Lyketsos C; Reich SG Psychosomatics; 2001; 42(6):477-81. PubMed ID: 11815682 [TBL] [Abstract][Full Text] [Related]
18. Recurrent priapism during treatment with clozapine and olanzapine. Compton MT; Saldivia A; Berry SA Am J Psychiatry; 2000 Apr; 157(4):659. PubMed ID: 10777416 [No Abstract] [Full Text] [Related]
19. [The role of olanzapine in Parkinsonian dopaminergic psychosis]. Durán-Ferreras E; Chacón-Peña JR; Durán-Quintana JA Rev Neurol; 2002 Oct 1-15; 35(7):691-6. PubMed ID: 12389159 [TBL] [Abstract][Full Text] [Related]
20. The efficacy of olanzapine, as needed, to treat acute agitation in juveniles. Sheikh RM; Ahmed K J Child Adolesc Psychopharmacol; 2002; 12(1):71-3. PubMed ID: 12014599 [No Abstract] [Full Text] [Related] [Next] [New Search]